...BRCA2 mutation status, ER status, and patient prognosis. Beyond its impact on research into the basic mechanisms of brea...
...BRCA2, and non-BRCA1/BRCA2 (BRCAX) tumors, by high-resolution comparative genomic hybridization, we have analyzed 77 tum...
...BRCA2, ATM, TP53, RB1, MAD2, BUB1, APC and beta-actin) in oocytes and embryos. A full characterization of all genes was ...
...BRCA2. The mutational spectra vary depending on the study populations and the criteria applied for patient selection. Th...
The spectrum of mutations in BRCA1 and BRCA2 among African Americans has not been well characterized because most studie...
Women with mutations of the genes BRCA1 or BRCA2 are at increased risk of ovarian cancer. Oral contraceptives protect ag...
...BRCA2 tumours, possibly suggesting a common pathway of disease. These findings need confirmation by more extensive studi...
...BRCA2 gene mutations are responsible for approximately 80% of the families with hereditary breast cancer. The diagnosis ...
...BRCA2 mutant cells. Surprisingly, we provide evidence that these proteins, like BRCA1 but unlike BRCA2, promote a second...
...BRCA2 susceptibility genes, familial history of breast cancer, age, higher socioeconomic status, ionizing radiation, tal...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
